共 5 条
[1]
[2]
Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence[J] David Castro-Diaz;Paulo C. R. Palma;Céline Bouchard;Francois Haab;Christian Hampel;Roberto Carone;Sebastian Zepeda Contreras;Henry Rodriguez Ginorio;Simon Voss;Ilker Yalcin;Richard C. Bump International Urogynecology Journal 2007,
[3]
Pharmacokinetics and Safety of Duloxetine; a Dual-Serotonin and Norepinephrine Reuptake Inhibitor[J] Amarnath Sharma;Mark J. Goldberg;Benito J. Cerimele The Journal of Clinical Pharmacology 2000,
[4]
Simultaneous monitoring of inhibition of serotonin uptake by platelets and plasma drug concentrations following administration of duloxetine; a new antidepressant candidate; to healthy volunteers[J] Jun Ishigooka;Etsuko Nagata;Akihiko Takahashi;Takeshi Sugiyama;Mitsutomo Uchiumi;Toshimasa Tsukahara;Mitsukuni Murasaki;Sadanori Miura;Takayoshi Oguma;Yoshitaka Yano Current Therapeutic Research 1997,
[5]
Chronic duloxetinedreatment induces specific changes in the expression of BDNFtranscripts and in the subcellular localization of the neurotrophinprotein GALABRESE F;MOLTENI R;MAJ P F;et al; Neuro Psycho Pharmacology 2007,